Clostridioides difficile colitis

Risk factors

Recent antibiotic use
Hospitalization
Gastric acid suppression (eg, PPI)

Pathogenesis

Disruption of intestinal flora — C difficile overgrowth
Toxins A & B disrupt cytoskeleton integrity & stimulate
inflammation

Pseudomembrane formation

Clinical presentation

Profuse watery diarrhea (most common)
Leukocytosis (~15,000/mm*)
Fulminant colitis/toxic megacolon

Stool PCR for C difficile genes*

Diagnosis ¢ Stool EIA for C difficile toxin & glutamate dehydrogenase
antigen
¢ Oral fidaxomicin or oral vancomycin
Treatment

IV metronidazole added for fulminant disease

